The NanoBiotechnology Group is mainly focused on the use of bioactive molecules and nanoparticles in nanomedicine and nanotechnology. It holds a multidisciplinary philosophy, combining the expertise in the use of modified oligonucleotides and nanostructures in nanomedicine. The group deals with several research lines, centered on the use of modified oligonucleotides to create new nanomedical tools and sensors. Specifically, the current research topics are:
- Nanoparticles in Drug Delivery, using different nanostructures to deliver different drugs and nucleic acids for the treatment of different diseases.
- Design of new strategies for an efficient editing of Uveal Melanoma and Pancreatic cancer cell lines based on CRISPR system delivery.
- Nanosensors for multiples diseases, such as Uveal, Melanoma, Pancreatic cancer or Duchenne Muscular Dystrophy.